Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Gemina Laboratories Ltd. is currently dealing with 1 pending office action in the Biotechnology & Pharmaceuticals technology area. This matter is assigned to 1 distinct examiner and 1 distinct art unit, reflecting a concentrated prosecution effort. The company's immediate success in the patent office is tied to this active case and the examiner's review. This focus within the Biotechnology & Pharmaceuticals sector allows the company to concentrate its technical expertise on the patent claims and examiner feedback.
The busiest examiner, NGUYEN, NAM P, is handling 1 pending office action, which is the only pending action in the company's portfolio. This means the practitioner's strategy must be aligned with the preferences and requirements of this examiner. Because there is only 1 distinct art unit involved, the technical and legal focus is narrow, allowing for a targeted response to the 1 pending office action. The outcome of this matter will be the primary indicator of the company's current progress in the Biotechnology & Pharmaceuticals sector. Practitioners should focus on the specific prior art and technical hurdles identified by the assigned examiner to advance the 1 pending office action.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Double-patenting + other | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| NGUYEN, NAM P | 1 | 54.8% | +48.7% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18181325 | DUAL-AFFINITY PROBES AND SYSTEMS FOR ANALYTE DETECTION | NGUYEN, NAM P | — |
| Art Unit | Apps |
|---|---|
| 1678 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18181325 | DUAL-AFFINITY PROBES AND SYSTEMS FOR ANALYTE DETECTION | NGUYEN, NAM P | 1678 | §102§112DP | Non-Final OA | — | Pending | Mar 09, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial